Cite

98O The immunomodulatory (IM) signature enhances prediction of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in triple negative breast cancers (TNBC) with moderate stromal tumour infiltrating lymphocytes (sTIL)

MLA

Elizabeth Ravenberg, et al. “98O The Immunomodulatory (IM) Signature Enhances Prediction of Pathologic Complete Response (PCR) to Neoadjuvant Therapy (NAT) in Triple Negative Breast Cancers (TNBC) with Moderate Stromal Tumour Infiltrating Lymphocytes (STIL).” Annals of Oncology, vol. 31, May 2020, p. S49. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........fca876a2364020830c5cb2281e145a1b&authtype=sso&custid=ns315887.



APA

Elizabeth Ravenberg, Banu Arun, Bora Lim, Jason B White, S. L. Moulder, Ravi Murthy, R. Pitpitan, Senthil Damodaran, Aysegul A. Sahin, Lei Huo, Jennifer K. Litton, Nour Abuhadra, Lumarie Santiago, NT Ueno, Beatriz E. Adrada, Nuhad K. Ibrahim, Ryan Sun, Alastair M. Thompson, Elizabeth A. Mittendorf, & Gaiane M. Rauch. (2020). 98O The immunomodulatory (IM) signature enhances prediction of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in triple negative breast cancers (TNBC) with moderate stromal tumour infiltrating lymphocytes (sTIL). Annals of Oncology, 31, S49.



Chicago

Elizabeth Ravenberg, Banu Arun, Bora Lim, Jason B White, S. L. Moulder, Ravi Murthy, R. Pitpitan, et al. 2020. “98O The Immunomodulatory (IM) Signature Enhances Prediction of Pathologic Complete Response (PCR) to Neoadjuvant Therapy (NAT) in Triple Negative Breast Cancers (TNBC) with Moderate Stromal Tumour Infiltrating Lymphocytes (STIL).” Annals of Oncology 31 (May): S49. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........fca876a2364020830c5cb2281e145a1b&authtype=sso&custid=ns315887.